FDA Orange Book
Generic for Lotemax
Lotemax contains loteprednol etabonate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Lotemax is loteprednol etabonate. 5 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 3 of the 4 Lotemax products the Orange Book lists.
Run it in Rivvi
Map Lotemax and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Lotemax products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| gel, ophthalmic | 0.5% | Marketed (Rx) | AB | 1 | AB |
| ointment, ophthalmic | 0.5% | Marketed (Rx) | None | 0 | None |
| suspension/drops, ophthalmic | 0.5% | Marketed (Rx) | AB | 5 | AB |
| suspension/drops, ophthalmic | 0.5% | Discontinued | None | 5 | AB |
NDA 202872, 200738, 020583, 020841, held by BAUSCH AND LOMB INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic loteprednol etabonate
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| SENTISS AG | 207609 | AB (A-rated, therapeutically equivalent) | April 17, 2019 | 0.5%, 0.5% |
| SENTISS AG | 212080 | AB (A-rated, therapeutically equivalent) | February 10, 2021 | 0.5% |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 212450 | AB (A-rated, therapeutically equivalent) | February 26, 2021 | 0.5%, 0.5% |
| LUPIN LTD | 215719 | AB (A-rated, therapeutically equivalent) | April 24, 2024 | 0.5%, 0.5% |
| PADAGIS US LLC | 215204 | AB (A-rated, therapeutically equivalent) | January 29, 2025 | 0.5%, 0.5% |
| AMNEAL EU LTD | 217484 | AB (A-rated, therapeutically equivalent) | May 20, 2025 | 0.5%, 0.5% |
Lotemax NDC codes
Questions
Is there a generic for Lotemax?
Yes. The generic name for Lotemax is loteprednol etabonate. 5 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 3 of the 4 Lotemax products the Orange Book lists.
What is the generic name for Lotemax?
The active ingredient in Lotemax is loteprednol etabonate, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Lotemax and Loteprednol Etabonate
- What is Lotemax used for?FDA label uses
- Is Lotemax a controlled substance?Federal schedule
- What is Loteprednol Etabonate used for?FDA label uses
- Is Loteprednol Etabonate a controlled substance?Federal schedule
- Generic for Lotemax SMFDA Orange Book
- Generic for AlrexFDA Orange Book
- Generic for EysuvisFDA Orange Book
- Generic for InveltysFDA Orange Book
- Corticosteroids listFDA drug class
- NDC 24208-299Lotemax NDC record
- NDC 24208-443Lotemax NDC record
- NDC 24208-503Lotemax NDC record